ABT

Abbott Laboratories
D

ABT

134.280
USD
0.21
(0.16%)
Market Closed
Volume
94,710
EPS
5
Div Yield
1.7
P/E
17
Market Cap
233,625,337,873
OverviewSignalsIdeasNews
Related Instruments
BDX
BDX
-0.560
(-0.32%)
176.660 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
BSX
BSX
0.625
(0.60%)
104.250 USD
DHR
DHR
1.050
(0.52%)
203.490 USD
GE
GE
2.280
(0.93%)
246.780 USD
JNJ
JNJ
0.570
(0.37%)
156.110 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
MMM
MMM
-1.660
(-1.08%)
152.270 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
TMO
TMO
1.69
(0.40%)
429.33 USD
More
News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

10 months ago
Economy News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

1 year ago
Stocks News
More

Title: Abbott Laboratories

Sector: Healthcare
Industry: Medical Devices
Abbott Laboratories is an American multinational healthcare company that develops, manufactures and markets a diversified line of healthcare products and services. Headquartered in Abbott Park, Illinois, the company was founded by physician Wallace Calvin Abbott in 1888. In 2013, the company split off its research division, AbbVie, leaving it to operate as an independent entity. Among its best-known products in medical devices, diagnostics and nutrition products are Pedialyte, Similac, Ensure, Glucerna, FreeStyle Libre, i-STAT and MitraClip.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.